EndeavourRx LLC
February 11, 2025
Plymouth
CNS/Neurological
Developing AMPAkines for spinal injury, ADHD and Central Apnea (Phase 2). Developing GABAkines for treatment resistant epilepsy and non-opioid pain management (preclinical).
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}